{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:56:50Z","timestamp":1787759810748,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is very important to treat adenomyosis which may cause infertility, menorrhagia, and dysmenorrhea for women at the reproductive age. High-intensity focused ultrasound (HIFU) is effective in destroying target tumor tissues without damaging the path of the ultrasound beam and surrounding normal tissues. The levonorgestrel-releasing intrauterine system (LN-IUS) is a medical system which is inserted into the uterine to provide medicinal treatment for temporary control of the symptoms caused by adenomyosis. This study was to investigate the effect of HIFU combined with the LN-IUS on adenomyosis. In the HIFU treatment, the parameters of the ultrasound were transmission frequency 0.8\u00a0MHz and input power 50\u2013400 W (350\u2009\u00b1\u200930), and the temperature in the target tissue under these conditions would reach 60\u2013100\u00a0\u00b0C (85\u00a0\u00b0C\u2009\u00b1\u20096.3\u00a0\u00b0C). Size reduction and blood flow signal decrease were used to assess the effect of combined treatment. In this study, 131 patients with adenomyosis treated with HIFU combined with LN-IUS were retrospectively enrolled. The clinical and follow-up data were analyzed. After treatment, the volume of the uterine lesion was significantly decreased with an effective rate of 72.1%, and the adenomyosis blood flow signals were significantly reduced, with an effective rate of 71.3%. At six months, the menstrual cycle was significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) decreased from 31.4\u2009\u00b1\u20093.5\u00a0days before treatment to 28.6\u2009\u00b1\u20091.9\u00a0days, the menstrual period was significantly shortened from 7.9\u2009\u00b1\u20091.2\u00a0days before HIFU to 6.5\u2009\u00b1\u20091.3\u00a0days, and the menstrual volume was significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) decreased from 100 to 49%\u2009\u00b1\u200913%. The serum hemoglobin significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) increased from 90.8\u2009\u00b1\u20096.2\u00a0g\/L before treatment to 121.6\u2009\u00b1\u200910.8\u00a0g\/L at six months for patients with anemia. Among seventy-two (92.3%) patients who finished the six-month follow-up, sixty-five (90.3%) patients had the dysmenorrhea completely relieved, and the other seven (9.7%) patients had only slight dysmenorrhea which did not affect their daily life. Adverse events occurred in 24 (18.3%) patients without causing severe consequences, including skin burns in two (1.5%) patients, skin swelling in four (3.1%), mild lower abdominal pain and low fever in 15 (11.5%), and subcutaneous induration in three (2.3%). Six months after treatment, no other serious side effects occurred in any patients with follow-up. In conclusions, the use of high-intensity focused ultrasound combined with the levonorgestrel-releasing intrauterine system for the treatment of adenomyosis is safe and effective even though the long-term effect remains to be confirmed.<\/jats:p>","DOI":"10.1038\/s41598-023-37096-y","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T09:02:19Z","timestamp":1687165339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Yuru","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"37096_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ultsonch.2015.05.031","volume":"27","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases. Ultrason. Sonochem. 27, 671\u2013676 (2015).","journal-title":"Ultrason. Sonochem."},{"key":"37096_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.tjog.2020.09.013","volume":"59","author":"CJ Jeng","year":"2020","unstructured":"Jeng, C. J., Ou, K. Y., Long, C. Y., Chuang, L. & Ker, C. R. 500 cases of high-intensity focused ultrasound (hifu) ablated uterine fibroids and adenomyosis. Taiwan J. Obstet. Gynecol. 59, 865\u2013871 (2020).","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"37096_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/0284185119891692","volume":"61","author":"C Li","year":"2020","unstructured":"Li, C. et al. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: Whole-tumor quantitative perfusion for prediction of immediate ablation response. Acta Radiol. 61, 1125\u20131133 (2020).","journal-title":"Acta Radiol."},{"key":"37096_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.663128","volume":"8","author":"MJ Yang","year":"2021","unstructured":"Yang, M. J., Yu, R. Q., Chen, W. Z., Chen, J. Y. & Wang, Z. B. A prediction of npvr >\/= 80% of ultrasound-guided high-intensity focused ultrasound ablation for uterine fibroids. Front. Surg. 8, 663128 (2021).","journal-title":"Front. Surg."},{"key":"37096_CR5","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.ultrasmedbio.2021.05.012","volume":"47","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Ultrasound-guided high-intensity focused ultrasound for devascularization of uterine fibroid: A feasibility study. Ultrasound Med. Biol. 47, 2622\u20132635 (2021).","journal-title":"Ultrasound Med. Biol."},{"key":"37096_CR6","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1148\/radiographics.19.suppl_1.g99oc03s161","volume":"19","author":"JY Byun","year":"1999","unstructured":"Byun, J. Y. et al. Diffuse and focal adenomyosis: Mr imaging findings. Radiographics 19, S161\u2013S170 (1999).","journal-title":"Radiographics"},{"key":"37096_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/GCO.0b013e32833bea2e","volume":"22","author":"X Dong","year":"2010","unstructured":"Dong, X. & Yang, Z. High-intensity focused ultrasound ablation of uterine localized adenomyosis. Curr. Opin. Obstet. Gynecol. 22, 326\u2013330 (2010).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"37096_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/humupd\/4.4.360","volume":"4","author":"H Ota","year":"1998","unstructured":"Ota, H., Igarashi, S., Hatazawa, J. & Tanaka, T. Is adenomyosis an immune disease?. Hum. Reprod. Update. 4, 360\u2013367 (1998).","journal-title":"Hum. Reprod. Update."},{"key":"37096_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/humupd\/4.4.323","volume":"4","author":"C Wood","year":"1998","unstructured":"Wood, C. Surgical and medical treatment of adenomyosis. Hum. Reprod. Update. 4, 323\u2013336 (1998).","journal-title":"Hum. Reprod. Update."},{"key":"37096_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1148\/radiol.2016141693","volume":"280","author":"JE Silberzweig","year":"2016","unstructured":"Silberzweig, J. E., Powell, D. K., Matsumoto, A. H. & Spies, J. B. Management of uterine fibroids: A focus on uterine-sparing interventional techniques. Radiology 280, 675\u2013692 (2016).","journal-title":"Radiology"},{"key":"37096_CR11","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","volume":"372","author":"EA Stewart","year":"2015","unstructured":"Stewart, E. A. Clinical practice. Uterine fibroids. N. Engl. J. Med. 372, 1646\u20131655 (2015).","journal-title":"N. Engl. J. Med."},{"key":"37096_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/02656736.2020.1734672","volume":"37","author":"N Barnat","year":"2020","unstructured":"Barnat, N. et al. Efficacy and safety assessment of an ultrasound-based thermal treatment of varicose veins in a sheep model. Int. J. Hyperth. 37, 231\u2013244 (2020).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1464-410X.1997.03235.x","volume":"79","author":"LD Sullivan","year":"1997","unstructured":"Sullivan, L. D., McLoughlin, M. G., Goldenberg, L. G., Gleave, M. E. & Marich, K. W. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br. J. Urol. 79, 172\u2013176 (1997).","journal-title":"Br. J. Urol."},{"key":"37096_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.18433\/J3ZP5F","volume":"17","author":"CP Phenix","year":"2014","unstructured":"Phenix, C. P., Togtema, M., Pichardo, S., Zehbe, I. & Curiel, L. High intensity focused ultrasound technology, its scope and applications in therapy and drug delivery. J. Pharm. Pharm. Sci. 17, 136\u2013153 (2014).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"37096_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/02656736.2020.1779357","volume":"37","author":"HP Kok","year":"2020","unstructured":"Kok, H. P. et al. Heating technology for malignant tumors: A review. Int. J. Hyperth. 37, 711\u2013741 (2020).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1540-8175.2001.00309.x","volume":"18","author":"S Vaezy","year":"2001","unstructured":"Vaezy, S., Martin, R. & Crum, L. High intensity focused ultrasound: A method of hemostasis. Echocardiography 18, 309\u2013315 (2001).","journal-title":"Echocardiography"},{"key":"37096_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ctrv.2011.08.004","volume":"38","author":"O Al-Bataineh","year":"2012","unstructured":"Al-Bataineh, O., Jenne, J. & Huber, P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat. Rev. 38, 346\u2013353 (2012).","journal-title":"Cancer Treat. Rev."},{"key":"37096_CR18","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.2174\/0929867327666201111143206","volume":"28","author":"LB Feril","year":"2021","unstructured":"Feril, L. B., Fernan, R. L. & Tachibana, K. High-intensity focused ultrasound in the treatment of breast cancer. Curr. Med. Chem. 28, 5179\u20135188 (2021).","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"37096_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/jcm9020460","volume":"9","author":"Z Izadifar","year":"2020","unstructured":"Izadifar, Z., Izadifar, Z., Chapman, D. & Babyn, P. An introduction to high intensity focused ultrasound: Systematic review on principles, devices, and clinical applications. J. Clin. Med. 9(2), 460 (2020).","journal-title":"J. Clin. Med."},{"key":"37096_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/02656736.2014.969789","volume":"31","author":"E Maloney","year":"2015","unstructured":"Maloney, E. & Hwang, J. H. Emerging hifu applications in cancer therapy. Int. J. Hyperth. 31, 302\u2013309 (2015).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/a-0820-5564","volume":"191","author":"M Marinova","year":"2019","unstructured":"Marinova, M., Wilhelm-Buchstab, T. & Strunk, H. Advanced pancreatic cancer: High-intensity focused ultrasound (hifu) and other local ablative therapies. Rofo. 191, 216\u2013227 (2019).","journal-title":"Rofo."},{"key":"37096_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/02656736.2020.1762006","volume":"37","author":"M Thudium","year":"2020","unstructured":"Thudium, M. et al. Multidisciplinary management and outcome in pancreatic cancer patients treated with high-intensity focused ultrasound. Int. J. Hyperth. 37, 456\u2013462 (2020).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00345-020-03301-0","volume":"39","author":"N Westhoff","year":"2021","unstructured":"Westhoff, N. et al. Treatment decision satisfaction and regret after focal hifu for localized prostate cancer. World J. Urol. 39, 1121\u20131129 (2021).","journal-title":"World J. Urol."},{"key":"37096_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12893-021-01307-y","volume":"21","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. Hifu for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: A prospective and propensity score-matched study. BMC Surg. 21, 308 (2021).","journal-title":"BMC Surg."},{"key":"37096_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0301-5629(90)90020-D","volume":"16","author":"DD Adler","year":"1990","unstructured":"Adler, D. D., Carson, P. L., Rubin, J. M. & Quinn-Reid, D. Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findings. Ultrasound Med. Biol. 16, 553\u2013559 (1990).","journal-title":"Ultrasound Med. Biol."},{"key":"37096_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/01443615.2019.1581740","volume":"39","author":"VYT Cheung","year":"2019","unstructured":"Cheung, V. Y. T. et al. Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: A preliminary experience. J. Obstet. Gynaecol. 39, 833\u2013839 (2019).","journal-title":"J. Obstet. Gynaecol."},{"key":"37096_CR27","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.ultrasmedbio.2019.08.022","volume":"45","author":"JS Lee","year":"2019","unstructured":"Lee, J. S., Hong, G. Y., Lee, K. H., Song, J. H. & Kim, T. E. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med. Biol. 45, 3214\u20133221 (2019).","journal-title":"Ultrasound Med. Biol."},{"key":"37096_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ejogrb.2020.11.049","volume":"256","author":"JY Lee","year":"2021","unstructured":"Lee, J. Y. et al. Efficacy and safety of transvaginal high-intensity focused ultrasound therapy in women with symptomatic uterine leiomyomas: A clinical trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 256, 302\u2013307 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"37096_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5732\/cjc.012.10104","volume":"32","author":"S Li","year":"2013","unstructured":"Li, S. & Wu, P. H. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer. Chin. J. Cancer. 32, 441\u2013452 (2013).","journal-title":"Chin. J. Cancer."},{"key":"37096_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.eprac.2022.02.011","volume":"28","author":"S Jasim","year":"2022","unstructured":"Jasim, S. et al. American association of clinical endocrinology disease state clinical review: The clinical utility of minimally invasive interventional procedures in the management of benign and malignant thyroid lesions. Endocr. Pract. 28, 433\u2013448 (2022).","journal-title":"Endocr. Pract."},{"key":"37096_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1055\/a-0591-3386","volume":"40","author":"M Marinova","year":"2019","unstructured":"Marinova, M. et al. Clinical effectiveness and potential survival benefit of us-guided high-intensity focused ultrasound therapy in patients with advanced-stage pancreatic cancer. Ultraschall. Med. 40, 625\u2013637 (2019).","journal-title":"Ultraschall. Med."},{"key":"37096_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40349-015-0043-6","volume":"3","author":"M Abel","year":"2015","unstructured":"Abel, M. et al. Ultrasound-guided trans-rectal high-intensity focused ultrasound (hifu) for advanced cervical cancer ablation is feasible: A case report. J. Ther. Ultrasound. 3, 21 (2015).","journal-title":"J. Ther. Ultrasound."},{"key":"37096_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/02656736.2021.1894359","volume":"38","author":"R Zhang","year":"2021","unstructured":"Zhang, R. et al. The safety and ablation efficacy of ultrasound-guided high-intensity focused ultrasound ablation for desmoid tumors. Int. J. Hyperth. 38, 89\u201395 (2021).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000516469","volume":"10","author":"G Mauri","year":"2021","unstructured":"Mauri, G. et al. European thyroid association and cardiovascular and interventional radiological society of europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur. Thyroid J. 10, 185\u2013197 (2021).","journal-title":"Eur. Thyroid J."},{"key":"37096_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","volume":"81","author":"D Reddy","year":"2022","unstructured":"Reddy, D. et al. Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: A multi-institute 15-year experience. Eur. Urol. 81, 407\u2013413 (2022).","journal-title":"Eur. Urol."},{"key":"37096_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/02656736.2022.2086712","volume":"39","author":"T Yang","year":"2022","unstructured":"Yang, T. et al. Effectiveness and safety of ultrasound-guided high-intensity focused ultrasound ablation for the treatment of colorectal cancer liver metastases. Int. J. Hyperth. 39, 829\u2013834 (2022).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.17219\/acem\/125433","volume":"29","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z. & Liang, P. Advances in ultrasound-guided thermal ablation for symptomatic benign thyroid nodules. Adv. Clin. Exp. Med. 29, 1123\u20131129 (2020).","journal-title":"Adv. Clin. Exp. Med."},{"key":"37096_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.12659\/PJR.890606","volume":"79","author":"J Filipowska","year":"2014","unstructured":"Filipowska, J. & Lozinski, T. Magnetic resonance-guided high-intensity focused ultrasound (mr-hifu) in treatment of symptomatic uterine myomas. Pol. J. Radiol. 79, 439\u2013443 (2014).","journal-title":"Pol. J. Radiol."},{"issue":"184","key":"37096_CR39","first-page":"e181","volume":"196","author":"K Funaki","year":"2007","unstructured":"Funaki, K. et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: Relationship between the therapeutic effects and signal intensity of preexisting t2-weighted magnetic resonance images. Am. J. Obstet. Gynecol. 196(184), e181-186 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"37096_CR40","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.7150\/thno.42830","volume":"10","author":"G Ning","year":"2020","unstructured":"Ning, G., Zhang, X., Zhang, Q., Wang, Z. & Liao, H. Real-time and multimodality image-guided intelligent hifu therapy for uterine fibroid. Theranostics. 10, 4676\u20134693 (2020).","journal-title":"Theranostics."},{"key":"37096_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/a-0817-5645","volume":"191","author":"F Siedek","year":"2019","unstructured":"Siedek, F. et al. Magnetic resonance-guided high-intensity focused ultrasound (mr-hifu): Technical background and overview of current clinical applications (part 1). Rofo. 191, 522\u2013530 (2019).","journal-title":"Rofo."},{"key":"37096_CR42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2214\/AJR.09.2842","volume":"194","author":"SD LeBlang","year":"2010","unstructured":"LeBlang, S. D., Hoctor, K. & Steinberg, F. L. Leiomyoma shrinkage after mri-guided focused ultrasound treatment: Report of 80 patients. AJR Am. J. Roentgenol. 194, 274\u2013280 (2010).","journal-title":"AJR Am. J. Roentgenol."},{"key":"37096_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236725","volume":"15","author":"D Che","year":"2020","unstructured":"Che, D., Yang, Z., Wei, H., Wang, X. & Gao, J. The adler grade by doppler ultrasound is associated with clinical pathology of cervical cancer: Implication for clinical management. PLoS ONE 15, e0236725 (2020).","journal-title":"PLoS ONE"},{"key":"37096_CR44","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7863\/jum.2002.21.11.1227","volume":"21","author":"WT Yang","year":"2002","unstructured":"Yang, W. T., Tse, G. M., Lam, P. K., Metreweli, C. & Chang, J. Correlation between color power doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J. Ultrasound Med. 21, 1227\u20131235 (2002).","journal-title":"J. Ultrasound Med."},{"key":"37096_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/CH-2012-1584","volume":"53","author":"DA Clevert","year":"2013","unstructured":"Clevert, D. A., D\u2019Anastasi, M. & Jung, E. M. Contrast-enhanced ultrasound and microcirculation: Efficiency through dynamics\u2013current developments. Clin. Hemorheol. Microcirc. 53, 171\u2013186 (2013).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"37096_CR46","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/jum.14573","volume":"37","author":"S Baggio","year":"2018","unstructured":"Baggio, S. et al. Influence of ulipristal acetate therapy on uterine fibroid-related symptoms and on uterine and fibroid volumes and vascularity indices assessed by ultrasound. J. Ultrasound Med. 37, 2215\u20132223 (2018).","journal-title":"J. Ultrasound Med."},{"key":"37096_CR47","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ultrasmedbio.2020.02.018","volume":"46","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. Comparison of focused ultrasound surgery and hysteroscopic resection for treatment of submucosal uterine fibroids (figo type 2). Ultrasound Med. Biol. 46, 1677\u20131685 (2020).","journal-title":"Ultrasound Med. Biol."},{"key":"37096_CR48","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1080\/03007995.2017.1372107","volume":"33","author":"AM Soliman","year":"2017","unstructured":"Soliman, A. M. et al. Impact of uterine fibroid symptoms on health-related quality of life of us women: Evidence from a cross-sectional survey. Curr. Med. Res. Opin. 33, 1971\u20131978 (2017).","journal-title":"Curr. Med. Res. Opin."},{"key":"37096_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00270-012-0505-y","volume":"36","author":"J Martin","year":"2013","unstructured":"Martin, J., Bhanot, K. & Athreya, S. Complications and reinterventions in uterine artery embolization for symptomatic uterine fibroids: A literature review and meta analysis. Cardiovasc. Interv. Radiol. 36, 395\u2013402 (2013).","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"37096_CR50","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/s-0028-1102999","volume":"25","author":"A Roberts","year":"2008","unstructured":"Roberts, A. Magnetic resonance-guided focused ultrasound for uterine fibroids. Semin. Interv. Radiol. 25, 394\u2013405 (2008).","journal-title":"Semin. Interv. Radiol."},{"key":"37096_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/02656736.2018.1473894","volume":"35","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int. J. Hyperth. 35, 56\u201361 (2018).","journal-title":"Int. J. Hyperth."},{"key":"37096_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jog.14571","volume":"47","author":"FZY Sun","year":"2021","unstructured":"Sun, F. Z. Y., You, M., Yang, Y., Yu, Y. & Xu, H. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness. J. Obstet. Gynaecol. Res. 47, 613\u2013620 (2021).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"37096_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/02656736.2021.1874063","volume":"38","author":"NHQ Hai","year":"2021","unstructured":"Hai, N. H. Q. & Guo, R. Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment. Int. J. Hyperth.. 38, 65\u201369 (2021).","journal-title":"Int. J. Hyperth.."},{"key":"37096_CR54","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2007.10.798","volume":"198","author":"SNA Cho","year":"2008","unstructured":"Cho, S. N. A. et al. Clinical effects of the levonorgestrelreleasing intrauterine device in patients with adenomyosis. Am. J. Obstet. Gynecol. 198, e1\u2013e7 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"37096_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.contraception.2007.05.091","volume":"76","author":"AMCN Bragheto","year":"2007","unstructured":"Bragheto, A. M. C. N., Bahamondes, L. & Petta, C. A. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 76, 195\u2013199 (2007).","journal-title":"Contraception"},{"key":"37096_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/humupd\/dms006","volume":"18","author":"AGS Maheshwari","year":"2012","unstructured":"Maheshwari, A. G. S., Fatima, F. & Bhattacharya, S. Adenomyosis and subfertility: A systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum. Reprod. Update. 18, 374\u2013392 (2012).","journal-title":"Hum. Reprod. Update."},{"key":"37096_CR57","doi-asserted-by":"crossref","unstructured":"Abou-Setta, A. M. A.-I. H., Farquhar, C. M. Levonorgestrel-releasing intrauterine device (lng-iud) for symptomatic endometriosis following surgery. Cochrane Datab. Syst. Rev. 18 (2006).","DOI":"10.1002\/14651858.CD005072.pub2"},{"key":"37096_CR58","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/01.AOG.0000295979.81092.e5","volume":"110","author":"JB Spies","year":"2007","unstructured":"Spies, J. B. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet. Gynecol. 110, 1427\u20131428 (2007) (author reply 1428-1429).","journal-title":"Obstet. Gynecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37096-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37096-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T10:18:18Z","timestamp":1687169898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37096-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37096"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37096-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9903"}}